Literature DB >> 22009367

Susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21, and 9q33.3 in a cohort of Caucasian women.

E Lerchbaum1, O Trummer, A Giuliani, H-J Gruber, T R Pieber, B Obermayer-Pietsch.   

Abstract

In a recent genome-wide association study investigating Han Chinese PCOS women 3 loci that are strongly associated with PCOS were identified on chromosome 2p16.3 (rs13405728), 2p21 (rs13429458), and 9q33.3 (rs2479106). The aim of the study was to investigate the impact of rs13405728, rs13429458, and rs2479106 variants on PCOS susceptibility in a Caucasian cohort of PCOS and control women. Metabolic, endocrine, and anthropometric measurements and oral glucose tolerance tests were performed in 545 PCOS and 317 control women. The rs13405728, rs13429458, and rs2479106 polymorphisms were genotyped. There was no significant difference in genotype frequencies of rs13405728 and rs13429458 variants between PCOS and controls. There was a trend towards an association of the rs2479106 variant with PCOS susceptibility (p=0.053). PCOS women with the rs2479106 GG genotype had significantly higher WHR than PCOS women carrying the AG and AA genotype (p=0.034 and p=0.020, respectively). Moreover, QChol/HDL and LDL levels were significantly higher in PCOS women carrying the rs2479106 GG genotype when compared to those carrying the AA genotype (p=0.024 and p=0.035, respectively). PCOS women carrying the G allele of rs13405728 had significantly higher AUCgluc, glucose-30 min, and AUCins levels than those carrying the AA genotype (p=0.039, p=0.047, and p=0.044, respectively). In PCOS women, rs13405728 genotypes are associated with glucose and insulin metabolism. Moreover, rs2479106 genotypes were associated with increased WHR levels and an adverse serum lipid profile. Further, we observed a trend towards decreased PCOS susceptibility within carriers of the rs2479106 G-allele. Further studies in large Caucasian PCOS cohorts are warranted to confirm our findings. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 22009367     DOI: 10.1055/s-0031-1286279

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  20 in total

1.  Persistence pays off for PCOS gene prospectors.

Authors:  Jerome F Strauss; Jan M McAllister; Margrit Urbanek
Journal:  J Clin Endocrinol Metab       Date:  2012-07       Impact factor: 5.958

2.  The contribution of rare genetic variants to the pathogenesis of polycystic ovary syndrome.

Authors:  Matthew Dapas; Andrea Dunaif
Journal:  Curr Opin Endocr Metab Res       Date:  2020-04-03

Review 3.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

Review 4.  Genetics of polycystic ovary syndrome.

Authors:  Corrine K Welt; Jessica M Duran
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

5.  Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry.

Authors:  Corrine K Welt; Unnur Styrkarsdottir; David A Ehrmann; Gudmar Thorleifsson; Gudmundur Arason; Jens A Gudmundsson; Carole Ober; Robert L Rosenfield; Richa Saxena; Unnur Thorsteinsdottir; William F Crowley; Kari Stefansson
Journal:  J Clin Endocrinol Metab       Date:  2012-04-30       Impact factor: 5.958

Review 6.  Genetics of the polycystic ovary syndrome.

Authors:  Gülüm Kosova; Margrit Urbanek
Journal:  Mol Cell Endocrinol       Date:  2012-10-16       Impact factor: 4.102

7.  Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry.

Authors:  Priscilla Mutharasan; Eugene Galdones; Beatriz Peñalver Bernabé; Obed A Garcia; Nadereh Jafari; Lonnie D Shea; Teresa K Woodruff; Richard S Legro; Andrea Dunaif; Margrit Urbanek
Journal:  J Clin Endocrinol Metab       Date:  2012-11-01       Impact factor: 5.958

8.  Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals.

Authors:  Meredith A Brower; Michelle R Jones; Jerome I Rotter; Ronald M Krauss; Richard S Legro; Ricardo Azziz; Mark O Goodarzi
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

9.  Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype.

Authors:  Jan M McAllister; Bhavi Modi; Bruce A Miller; Jessica Biegler; Richard Bruggeman; Richard S Legro; Jerome F Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

10.  Three-Dimensional Genome Interactions Identify Potential Adipocyte Metabolism-Associated Gene STON1 and Immune-Correlated Gene FSHR at the rs13405728 Locus in Polycystic Ovary Syndrome.

Authors:  Can-Hui Cao; Ye Wei; Rang Liu; Xin-Ran Lin; Jia-Qi Luo; Qiu-Ju Zhang; Shou-Ren Lin; Lan Geng; Si-Kang Ye; Yu Shi; Xi Xia
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-24       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.